Application 202030
- Type
- ANDA
- Sponsor
- AMRING PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | BROMFENAC SODIUM | BROMFENAC SODIUM | SOLUTION/DROPS;OPHTHALMIC | EQ 0.09% ACID | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A202030-001 | BROMFENAC SODIUM | BROMFENAC SODIUM | EQ 0.09% ACID | SOLUTION/DROPS / OPHTHALMIC | 2013-01-09 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-10-28 04:53 UTC | 2022-10 | A202030-001 | BROMFENAC SODIUM | EQ 0.09% ACID | SOLUTION/DROPS / OPHTHALMIC | 2013-01-09 | f41ea6bd6efb… | ||
| 2022-09-29 23:25 UTC | 2022-09 | A202030-001 | BROMFENAC SODIUM | EQ 0.09% ACID | SOLUTION/DROPS / OPHTHALMIC | 2013-01-09 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A202030-001 | BROMFENAC SODIUM | EQ 0.09% ACID | SOLUTION/DROPS / OPHTHALMIC | 2013-01-09 | cb3db0bc1861… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A202030-001 | BROMFENAC SODIUM | EQ 0.09% ACID | SOLUTION/DROPS / OPHTHALMIC | 2013-01-09 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Bromfenac Ophthalmic Solution, 0.07% | BROMFENAC SODIUM | Apotex Corp. | 4246c669-3c2a-2a2b-3b1c-696deb4ab519 | 2026-06-15 | Warnings, Adverse reactions | BROMFENAC SODIUM |
| bromfenac ophthalmic solution | BROMFENAC SODIUM | Bausch & Lomb Americas Inc. | 246e2110-6a2d-4e22-8e37-72d80796b9af | 2026-05-05 | Warnings, Adverse reactions | BROMFENAC SODIUM |
| Prolensa | BROMFENAC SODIUM | Bausch & Lomb Incorporated | 4e072537-f73c-4a96-a65f-e2805ce112d8 | 2026-05-05 | Warnings, Adverse reactions | BROMFENAC SODIUM |
| bromfenac ophthalmic solution | BROMFENAC SODIUM | Dr. Reddy's Laboratories Inc. | fa249b9e-931c-454d-ba06-33139d5580e7 | 2026-05-05 | Warnings, Adverse reactions | BROMFENAC SODIUM |
| BROMFENAC SODIUM | BROMFENAC SODIUM | Alembic Pharmaceuticals Inc. | f6911061-d00e-466d-b623-f81730f38f98 | 2025-04-07 | Warnings, Adverse reactions | BROMFENAC SODIUM BROMFENAC SODIUM |
| bromfenac sodium | BROMFENAC SODIUM | Lupin Pharmaceuticals, Inc. | 26f3e5b3-a739-4b09-8046-e71ecb3a5a7b | 2025-03-27 | Warnings, Adverse reactions | bromfenac sodium BROMFENAC SODIUM |
| BROMFENAC SODIUM | BROMFENAC SODIUM | Alembic Pharmaceuticals Limited | f66f1436-daaa-412a-8822-c64866cfeada | 2024-07-09 | Warnings, Adverse reactions | BROMFENAC SODIUM BROMFENAC SODIUM |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.